MYELOPROLIFERATIVE NEOPLASM

This adverse event was reported 663 times

These drugs are most commonly taken by patients reporting MYELOPROLIFERATIVE NEOPLASM:

# Drug Count
0 RUXOLITINIB 120
1 CYCLOPHOSPHAMIDE 73
2 CYCLOPHOSPHAMIDE FOR INJECTION 73
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 73
4 RITUXIMAB 60
5 HYDROXYUREA 52
6 PREDNISONE 51
7 ASPIRIN 42
8 ASPIRIN 325 MG 42
9 ASPIRIN 81 MG 42
See all common drugs associated with MYELOPROLIFERATIVE NEOPLASM

MYELOPROLIFERATIVE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANAGRELIDE HYDROCHLORIDE 7 0.0060
1 HYDROXYUREA 52 0.0024
2 DECITABINE 10 0.0023
3 RUXOLITINIB 120 0.0016
4 PACRITINIB 5 0.0016
5 FEDRATINIB HYDROCHLORIDE 2 0.0015
6 BREXUCABTAGENE AUTOLEUCEL 3 0.0014
7 DORAVIRINE 1 0.0013
8 LUSPATERCEPT 3 0.0011
9 AXICABTAGENE CILOLEUCEL 11 0.0011
See all drugs enriched for association with MYELOPROLIFERATIVE NEOPLASM